You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Claims for Patent: 9,205,056

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,205,056

Title:	Controlled release hydrocodone formulations
Abstract:	A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.
Inventor(s):	Oshlack; Benjamin (Boca Raton, FL), Huang; Hua-Pin (Englewood Cliffs, NJ), Masselink; John K. (Old Tappan, NJ), Tonelli; Alfred (Congers, NY)
Assignee:	Purdue Pharma L.P. (Stamford, CT)
Application Number:	14/728,023
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,205,056
Patent Claims:	1.sup.th edition," 1989, Merck & Co. CP002606249. cited by applicant . Merk Index, 13.sup.th edition, entry 4806: hydrocodone (2001). cited by applicant . EPI Journal Feb. 2007, pp. 59-60; David Harrison; "Divisional Application a continuing problem" (2007). cited by applicant . Document CA/PL 17/07; "Misuse of Divisional Applications," by the EPO President, addressed to the EPO Committee of Patent Law. Presented at the EPO Administrative Council, dated Oct. 5, 2007. cited by applicant . Document CA/PL 3/08, presented by epi and other Professional Representatives, addressed to the EPO Committee of Patent Law. Presented at the EPO Administrative Council, dated Feb. 14, 2008. cited by applicant . Summons to Attend Oral Proceedings issued in connection with European Patent Application No. 05019453.9 on Jul. 23, 2010. cited by applicant . English translation of Office Action issued by Japanese Patent Office in connection with corresponding Japanese Patent Application No. 2001-534353 on May 25, 2010. cited by applicant . The Office Action issued in connection with Japanese patent application No. 2013-168584 on Sep. 16, 2014. cited by applicant . Claims Pending in U.S. Appl. No. 12/982,386 on Oct. 20, 2014. cited by applicant . Claims Pending in U.S. Appl. No. 13/833,263 on Oct. 20, 2014. cited by applicant . Claims Pending in U.S. Appl. No. 14/094,968 on Oct. 20, 2014. cited by applicant . Claims Pending in U.S. Appl. No. 14/483,395 on Oct. 20, 2014. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Oct. 9, 2014. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Aug. 13, 2014. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Dec. 19, 2013. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Sep. 4, 2013. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Apr. 30, 2013. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Dec. 27, 2012. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Nov. 5, 2012. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Apr. 10, 2012. cited by applicant . The Declaration of Benjamin Oshlack filed in U.S. Appl. No. 13/833,263 on Dec. 24, 2014. cited by applicant . Claims pending in U.S. Appl. No. 13/833,263 on Jan. 5, 2015. cited by applicant . Claims pending in U.S. Appl. No. 14/094,968 on Jan. 5, 2015. cited by applicant . Claims pending in U.S. Appl. No. 12/982,386 on Jan. 5, 2015. cited by applicant . Claims pending in U.S. Appl. No. 14/483,395 on Jan. 13, 2015. cited by applicant . An English translation of the Notice on Reexamination issued in connection with Chinese patent application No. 200810125922.X on Dec. 3, 2014. cited by applicant . Claims pending in U.S. Appl. No. 14/635,198 on Mar. 10, 2015. cited by applicant . Amendment after final action under 37 C.F.R. .sctn. 1.116 filed in connection with U.S. Appl. No. 11/372,857 on Mar. 2, 2015. cited by applicant . Declaration under 37 C.F.R. .sctn. 1.132 by Gurvinder Singh Rekhi filed in connection with U.S. Appl. No. 11/372,857 on Mar. 6, 2015. cited by applicant . Declaration of Interference issued in connection with U.S. Appl. Nos. 11/372,857; 13/833,263 and 14/094,968 on Apr. 8, 2015. cited by applicant . Claims pending in U.S. Appl. No. 14/635,198 on Mar. 30, 2015. cited by applicant . Claims pending in U.S. Appl. No. 14/672,894 on Mar. 30, 2015. cited by applicant . Claims pending in U.S. Appl. No. 14/673,447 on Mar. 30, 2015. cited by applicant . Interference 106,022, Paper 187, Purdue Opposition 1, Sep. 11, 2015. cited by applicant . Interference 106,022, Paper 191, Purdue Opposition 3, Sep. 11, 2015. cited by applicant . Interference 106,022, Paper 192, Purdue Opposition 5, Sep. 11, 2015. cited by applicant . Interference 106,022, Paper 193, Purdue Opposition 6, Sep. 11, 2015. cited by applicant . Interference 106,022, Paper 187, Recro Opposition 1, Sep. 11, 2015. cited by applicant . Interference 106,022, Paper 188, Recro Opposition 2, Sep. 11, 2015. cited by applicant . Interference 106,022, Paper 190, Recro Opposition 5, Sep. 11, 2015. cited by applicant . Interference 106,022, Paper 189, Recro Opposition 5, Sep. 11, 2015. cited by applicant . Interference 106,022, Paper 205, Recro Substitute Opposition 4, Sep. 18, 2015. cited by applicant . Interference 106,022, Paper 204, Recro Substitute Opposition 5, Sep. 18, 2015. cited by applicant . Interference 106,022, Exhibit 1047, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 1048, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 1049, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 1050, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 1051, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 1052, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 1053, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2065, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2066, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2067, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2068, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2069, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2070, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2071, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2072, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2073, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2074, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2075, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2081, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2077, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2078, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2079, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2080, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2082, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2083, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2084, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2085, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2086, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2087, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2088, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2089, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2090, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2091, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2092, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2093, Sep. 11, 2015. cited by applicant . Interference 106,022, Exhibit 2094, Sep. 11, 2015. cited by applicant . Allowed Claims of U.S. Appl. No. 14/673,447; Sep. 24, 2015. cited by applicant . Allowed Claims of U.S. Appl. No. 14/672,894, Sep. 24, 2015. cited by applicant . Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms Containing Certain Active Moieties/Active Ingredients Based on a Biopharmaceutics Classification System (Issued Jan. 1999, Posted Feb. 16, 1999). cited by applicant . J. W. Barnhart, .et. al., Gas Chromatographic Determination of Hydrocodone in Serum, 130 J. Chromatography 243-49, Abstract (1977). cited by applicant . Interference 106,022, Paper 6 Oshlack Notice of Related Proceedings, Apr. 22, 2015. cited by applicant . Interference 106,022, Paper 12 John G. Devane Notice of Related Proceedings, Apr. 22, 2015. cited by applicant . Interference 106,022, Paper 14 Redeclaration 37 C.F.R. 203(c), Apr. 23, 2015. cited by applicant . Interference 106,022, Paper 18 Purdue Pharma Motion List, May 7, 2015. cited by applicant . Interference 106,022, Paper 19 Recro Motion List, May 8, 2015. cited by applicant . Interference 106,022, Paper 20 Recro Statement Concerning Other Proceedings, May 8, 2015. cited by applicant . Interference 106,022, Paper 21 Order Authorizing Motions and Setting Times, May 19, 2015. cited by applicant . Interference 106,022, Paper 22 Redeclaration 37 C.F.R. 41.203(c), May 19, 2015. cited by applicant . Interference 106,022, Paper 25 Decision Miscellaneous Motion Bd R 121(a)(3), Jul. 2, 2015. cited by applicant . Interference 106,022, Paper 148 Recro Motion 3, Jul. 10, 2015. cited by applicant . Interference 106,022, Paper 123 Recro Motion 1, Jul. 10, 2015. cited by applicant . Interference 106,022, Paper 140 Recro Motion 5, Jul. 10, 2015. cited by applicant . Interference 106,022, Paper 27 Recro Exhibit List, Jul. 10, 2015. cited by applicant . Interference 106,022, Paper 142 Purdue Pharma Exhibit List, Jul. 10, 2015. cited by applicant . Interference 106,022, Paper 143 Purdue Pharma Motion 1, Jul. 10, 2015. cited by applicant . Interference 106,022, Paper 144 Purdue Pharma Motion 2, Jul. 10, 2015. cited by applicant . Interference 106,022, Paper 145 Purdue Pharma Motion 4, Jul. 10, 2015. cited by applicant . Interference 106,022, Paper 152 Order--Responsive Motion, Jul. 24, 2015. cited by applicant . Interference 106,022, Paper 154 Purdue Motion 5, Jul. 31, 2015. cited by applicant . Interference 106,022, Paper 163 Recro Motion 6, Jul. 31, 2015. cited by applicant . Interference 106,022, Paper 159 Recro Updated Exhibit List, Jul. 31, 2015. cited by applicant . Interference 106,022, Exhibit 2001, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2002, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2003, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2004, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2005, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2006, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2007, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2008, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2009, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2010, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2011, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2012, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2013, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2014, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2015, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2016, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2017, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2018, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2021, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2022, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2023, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2025, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2026, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2027, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2028, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2029, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2030, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2041, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2064, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 2065, Jul. 31, 2015. cited by applicant . Interference 106,022, Exhibit 2066, Jul. 31, 2015. cited by applicant . Interference 106,022, Exhibit 2067, Jul. 31, 2015. cited by applicant . Interference 106,022, Exhibit 2068, Jul. 31, 2015. cited by applicant . Interference 106,022, Exhibit 2069, Jul. 31, 2015. cited by applicant . Interference 106,022, Exhibit 2070, Jul. 31, 2015. cited by applicant . Interference 106,022, Exhibit 2071, Jul. 31, 2015. cited by applicant . Interference 106,022, Exhibit 1001, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1002, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1003, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1004, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1005, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1006, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1007, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1008, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1009, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1010, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1011, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1012, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1013, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1014, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1015, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1016, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1017, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1019, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1020, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1021, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1022, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1023, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1024, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1025, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1026, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1027, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1028, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1029, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1030, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1041, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1042, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1043, Jul. 10, 2015. cited by applicant . Interference 106,022, Exhibit 1044, Jul. 10, 2015. cited by applicant . English translation of the Office Action issued in connection with Japanese Application No. 2014-182108 on Aug. 11, 2015. cited by applicant . Claims pending in U.S. Appl. No. 14/706,699 on Aug. 21, 2015. cited by applicant . Claims pending in U.S. Appl. No. 14/727,985 on Aug. 21, 2015. cited by applicant . Claims pending in U.S. Appl. No. 14/727,997 on Aug. 21, 2015. cited by applicant . Claims pending in U.S. Appl. No. 14/672,894 on Aug. 21, 2015. cited by applicant . Claims pending in U.S. Appl. No. 14/673,447 on Aug. 21, 2015. cited by applicant.

Primary Examiner: Sasan; Aradhana
Attorney, Agent or Firm: Davidson, Davidson & Kappel, LLC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.